Extracellular Vesicles as Drug Delivery System for the Treatment of Neurodegenerative Disorders: Optimization of the Cell Source
Extracellular vesicles (EVs) represent a next generation drug delivery system that combines nanoparticle size with extraordinary ability to cross biological barriers, reduced immunogenicity, and low offsite toxicity profiles. A successful application of this natural way of delivering biological comp...
Main Authors: | Matthew J. Haney, Yuling Zhao, John K. Fallon, Yue Wang, Samuel M. Li, Emily E. Lentz, Dorothy Erie, Philip C. Smith, Elena V. Batrakova |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2021-12-01
|
Series: | Advanced NanoBiomed Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/anbr.202100064 |
Similar Items
-
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
by: Yuling Zhao, et al.
Published: (2022-06-01) -
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
by: Matthew J. Haney, et al.
Published: (2020-05-01) -
Extracellular Vesicles as Drug Delivery System for the Treatment of Neurodegenerative Disorders: Optimization of the Cell Source
by: Matthew J. Haney, et al.
Published: (2023-06-01) -
Therapeutic potential of extracellular vesicles in Parkinson’s disease
by: Michelli Ramires Teixeira, et al.
Published: (2023-06-01) -
Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
by: Natalia L. Klyachko, et al.
Published: (2020-12-01)